Melanie D. Whittington

Statistics

Publications

Citations

899

H-Index

Active since

2016

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Institute for Clinical and Economic Review

University of Colorado Denver

University of California, San Francisco

Children's Hospital Colorado

Melanie D. Whittington is an author at University of Colorado Anschutz Medical Campus specializing in pharmacoeconomics, pharmacy, and cost-effectiveness analysis.

ORCID

Publications per year

2016–2024

Publications

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma

Melanie D. Whittington, R. Brett McQueen, Daniel A. Ollendorf et al. · JAMA Network Open · 2019 · 92 citations · Full text

Medicine, Oncology, Pharmacoeconomics +14

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia

Melanie D. Whittington, R. Brett McQueen, Daniel A. Ollendorf et al. · JAMA Pediatrics · 2018 · 91 citations · Full text

Medicine, Oncology, Pediatrics +17

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis

Melanie D. Whittington, R. Brett McQueen, Daniel A. Ollendorf et al. · Annals of Allergy Asthma & Immunology · 2016 · 83 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +14

Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey

Jonathan D. Campbell, Melanie D. Whittington, Chong Kim et al. · Epilepsy & Behavior · 2018 · 67 citations · Full text

Nursing, Child Health, Health Assessment +16

Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease

Melanie D. Whittington, Jonathan D. Campbell, David M. Rind et al. · Neurology · 2022 · 49 citations

Pharmacy, Geriatric Medicine, Pharmacoeconomics +17

1–5 of 30